|
End-of-day quote
Nasdaq
|
||
| - | - |
|
| Manager | Title | Age | Since |
|---|---|---|---|
Reinhard Kandera
DFI | Director of Finance/CFO | 56 | - |
Franck Grimaud
PRN | Corporate Officer/Principal | 59 | 01/12/2015 |
Robert C. Seid
PRN | Corporate Officer/Principal | - | 01/08/2008 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 87 | 05/07/2006 | |
F. Weller Meyer
BRD | Director/Board Member | 83 | 01/01/2006 |
Richard Douglas
BRD | Director/Board Member | 73 | 01/01/2002 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.19% | +11.31% | +67.86% | +150.58% | 1,263B | |
| -0.73% | +3.56% | +44.51% | +85.81% | 658B | |
| +1.41% | +3.24% | +29.22% | +107.83% | 521B | |
| +0.42% | +3.20% | +54.15% | +67.18% | 391B | |
| +2.18% | +2.93% | +73.30% | +45.62% | 369B | |
| +1.12% | +4.52% | +35.30% | +58.08% | 307B | |
| +6.96% | +8.86% | +11.27% | +36.62% | 290B | |
| +1.15% | +6.09% | +59.59% | +77.06% | 252B | |
| +3.06% | +9.38% | +44.11% | +119.47% | 212B | |
| Average | +1.73% | +5.90% | +46.59% | +83.14% | 473.55B | |
| Weighted average by Cap. | +1.19% | +6.60% | +50.88% | +98.31% |
Employees
-
Sector
Pharmaceuticals
- Stock Market
- Stocks
- Stock
Select your edition
All financial news and data tailored to specific country editions
